Posted on 6/19/20
It's Time To Invest In Selecta Biosciences As They Ink Massive $100 Million Upfront Deal
Summary$230 million market cap is extremely low after signing a $630 million agreement with Sobi, which gives $100 million upfront and tiered royalties for Gout indication.Potential . . .
Boston
